CO6660470A2 - Componentes de la pared de células de levadura y detección de los mismos - Google Patents

Componentes de la pared de células de levadura y detección de los mismos

Info

Publication number
CO6660470A2
CO6660470A2 CO12225402A CO12225402A CO6660470A2 CO 6660470 A2 CO6660470 A2 CO 6660470A2 CO 12225402 A CO12225402 A CO 12225402A CO 12225402 A CO12225402 A CO 12225402A CO 6660470 A2 CO6660470 A2 CO 6660470A2
Authority
CO
Colombia
Prior art keywords
yeast cell
detection
cell wall
glucan
components
Prior art date
Application number
CO12225402A
Other languages
English (en)
Inventor
Colm Moran
Stefan Kwiatkowski
Alexandros Yiannikouris
Ursula Anne Thielen
Original Assignee
Alltech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alltech Inc filed Critical Alltech Inc
Publication of CO6660470A2 publication Critical patent/CO6660470A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961Plant cells or fungi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/395Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Saccharomyces
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/14Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar alpha-D-Glucans, i.e. having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/24Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar beta-D-Glucans, i.e. having beta 1,n (n=3,4,6) linkages between saccharide units, e.g. xanthan

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a aditivos para forrajes animales y detección de los mismos en productos de forraje. Adicionalmente, la presente invención se refiere a componentes de la pared de células de levadura, sus métodos de: aislamiento, y composiciones y métodos para la detección inmunológica de los mismos. Más específicamente la presente invención se relaciona con un método para detectar células de levadura en una muestra, un método para preparar una composición inmunogénica que comprende un carbohidrato de pared en la célula de levadura, una composición inmunogénica que comprende (1-4)- -(1-6,)- -D-glucano covalentemente ligado a una proteína, una composición que comprende un anticuerpo capaz de unirse a un carbohidrato de pared de célula de levadura seleccionado del grupo que consiste de (1?4)-a-D-glucano, (1?6)-ß-D-glucano, y (1?4,)-a-(7?6,)-ß-D-glucano, un método para preparar anticuerpos para detectar la pared de células de levadura en una muestra y un kit para 1cm detección de la pared de células de levadura en una muestra.
CO12225402A 2010-05-14 2012-12-12 Componentes de la pared de células de levadura y detección de los mismos CO6660470A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33499510P 2010-05-14 2010-05-14

Publications (1)

Publication Number Publication Date
CO6660470A2 true CO6660470A2 (es) 2013-04-30

Family

ID=44912110

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12225402A CO6660470A2 (es) 2010-05-14 2012-12-12 Componentes de la pared de células de levadura y detección de los mismos

Country Status (25)

Country Link
US (1) US20110281283A1 (es)
EP (1) EP2569632B1 (es)
JP (1) JP2013532276A (es)
KR (1) KR101440818B1 (es)
CN (1) CN102939537B (es)
AU (1) AU2011252840B2 (es)
BR (1) BR112012030535B1 (es)
CA (1) CA2798328A1 (es)
CL (1) CL2012003165A1 (es)
CO (1) CO6660470A2 (es)
DK (1) DK2569632T3 (es)
EA (1) EA201291091A1 (es)
ES (1) ES2691260T3 (es)
IL (1) IL222789A (es)
MX (1) MX2012013170A (es)
MY (1) MY173081A (es)
NZ (2) NZ603340A (es)
PE (1) PE20130526A1 (es)
PL (1) PL2569632T3 (es)
PT (1) PT2569632T (es)
RS (1) RS57937B1 (es)
SG (1) SG185485A1 (es)
UA (1) UA103283C2 (es)
WO (1) WO2011143613A1 (es)
ZA (1) ZA201208200B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3119901T3 (pl) 2014-03-21 2021-11-29 Dsm Ip Assets B.V. Sposób traktowania ścian komórkowych drożdży beta-1,3-glukanazą wytwarzającą laminaripentaozę
US12019071B2 (en) * 2015-05-08 2024-06-25 Waters Technologies Corporation Composition and methods for extracting mycotoxins
CN105137084B (zh) * 2015-08-20 2016-09-28 厦门大学 一种葡聚糖的夹心酶联免疫吸附测定方法
JP6530846B1 (ja) * 2018-10-09 2019-06-12 アサヒグループホールディングス株式会社 免疫賦活剤及び感染予防方法
CN114196216B (zh) * 2021-12-27 2023-01-06 杭州靡特洛新材料科技有限公司 一种基于酒糟废弃物的全生物降解热塑水溶膜及其制备方法和应用
CN117126753B (zh) * 2023-10-26 2024-04-09 中粮营养健康研究院有限公司 产多糖酿酒酵母及其在龙眼葡萄酒酿造中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2130177T3 (es) 1991-08-10 1999-07-01 Medical Res Council Tratamiento de poblaciones de celulas.
AU690528B2 (en) 1992-12-04 1998-04-30 Medical Research Council Multivalent and multispecific binding proteins, their manufacture and use
PT664671E (pt) * 1993-08-06 2003-01-31 Biotec Pharmacon Asa Racoes para animais compreendendo glucano de levedura
DE4402065A1 (de) * 1994-01-25 1995-09-07 Behringwerke Ag Saccharomyces-spezifische Antigene und Antikörper, deren Herstellung und Verwendung
US6214337B1 (en) * 1995-04-18 2001-04-10 Biotec Asa Animal feeds comprising yeast glucan
ATE312194T1 (de) * 1998-04-17 2005-12-15 Biotrex S R L Produkt auf basis von polysacchariden aus backhefe und seine verwendung als additiv fur backwaren
EP1234886A1 (en) * 2001-02-23 2002-08-28 Universiteit van Amsterdam A method for detecting beta-1,6-glucan synthase activity
GB0211118D0 (en) * 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
AU2004287061B2 (en) * 2003-10-31 2011-01-06 Immunetics, Inc. Rapid peptidoglycan-based assay for detection of bacterial contamination of platelets
US20050020490A1 (en) * 2004-10-18 2005-01-27 Progressive Bioactives Incorporated A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals.
US20080102486A1 (en) * 2006-10-27 2008-05-01 Horgan Karina A Method for detection of yeast cell wall
US8933133B2 (en) * 2006-12-14 2015-01-13 Adm Alliance Nutrition, Inc. Animal feeds containing polyols
JP5054425B2 (ja) * 2007-05-07 2012-10-24 尚仁 大野 抗β−1,6−グルカン・モノクローナル抗体
CN101353383B (zh) * 2008-09-17 2010-12-08 山东京博控股发展有限公司 水溶性酵母β-葡聚糖及其制备方法
CN101403749B (zh) * 2008-11-17 2012-11-07 北京大学 通过葡聚糖特异性抗体辅助诊断自身免疫性疾病的试剂盒

Also Published As

Publication number Publication date
RS57937B1 (sr) 2019-01-31
DK2569632T3 (en) 2018-11-19
NZ623714A (en) 2015-10-30
EA201291091A1 (ru) 2013-05-30
MY173081A (en) 2019-12-25
CN102939537B (zh) 2016-09-14
NZ603340A (en) 2014-04-30
UA103283C2 (ru) 2013-09-25
PL2569632T3 (pl) 2019-02-28
IL222789A0 (en) 2012-12-31
BR112012030535B1 (pt) 2021-06-01
PE20130526A1 (es) 2013-05-05
AU2011252840B2 (en) 2014-07-03
BR112012030535A2 (pt) 2018-01-16
CA2798328A1 (en) 2011-11-17
JP2013532276A (ja) 2013-08-15
PT2569632T (pt) 2018-11-20
EP2569632A1 (en) 2013-03-20
IL222789A (en) 2016-09-29
ES2691260T3 (es) 2018-11-26
ZA201208200B (en) 2014-01-29
CN102939537A (zh) 2013-02-20
SG185485A1 (en) 2012-12-28
WO2011143613A1 (en) 2011-11-17
MX2012013170A (es) 2013-01-17
EP2569632B1 (en) 2018-08-15
EP2569632A4 (en) 2014-01-08
KR101440818B1 (ko) 2014-11-03
US20110281283A1 (en) 2011-11-17
KR20130038863A (ko) 2013-04-18
CL2012003165A1 (es) 2013-09-23

Similar Documents

Publication Publication Date Title
CO6660470A2 (es) Componentes de la pared de células de levadura y detección de los mismos
EP3955004A3 (en) Use of fatty acids in methods for detecting cancer
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
WO2012051211A3 (en) Antigen delivery platforms
AR089178A1 (es) Anticuerpos anti-il-36r
BRPI0906060A2 (pt) anticorpos isolados, métodos de preparo de um anticorpo anti-clostridium difficile, composição e método para a detecção da presença de um esporo de clostridium difficile em uma amostra
MX345092B (es) Anticuerpos anti-tau humanos,.
ES2479542T1 (es) Métodos y composiciones para su uso en terapias celulares
WO2012129363A3 (en) Single cell nucleic acid detection and analysis
BR112012031071A2 (pt) 8-proteínas de ligação à il-1
AR092487A2 (es) Anticuerpos contra la angiopoyetina 2 humana
EA201592269A1 (ru) Способы и композиции для снижения иммуносупрессии опухолевыми клетками
EA201591020A1 (ru) Человеческие анти-тау антитела
BR122019026188A8 (pt) Métodos para determinar se um indivíduo tem doença hepática gordurosa não alcoólica (nafld), se um indivíduo com esteatose não alcoólica tem esteato-hepatite não alcoólica e para monitorar um indivíduo com esteatose não alcoólica para o desenvolvimento de nash
EA201791610A1 (ru) Проникающие в клетку антитела
MX2015003150A (es) Anticuerpos específicos de polipeptido amiloide de islote humano (hiapp) y sus usos.
MX2013008471A (es) Metodos y aparatos para la deteccion de sensibilidad al gluten y su diferenciacion de la enfermedad celiaca.
AU2011285694A8 (en) Detection of degradation products of canine NT-proBNP
HK1126274A1 (en) T cell assays t
WO2008073895A3 (en) Methods and devices for testing saliva
BR112012033163A2 (pt) ''anticorpos monoclonais, linhagens celulares, usos de um anticorpo, kit, métodos para detectar um anticorpo, composição de anticorpo e uso de uma composição de anticorpo''
WO2012103337A3 (en) Assays and methods to sequence microbes directly from immune complexes
BR112013004594A2 (pt) método para a determinação de um conteúdo de antígeno
BRPI1013427A2 (pt) anticorpo monoclonal humano para lipopolissacarídeos (lps) de serotipo iats o1 de pseudomonas aeruginosa, hibridoma, ácido nucleico, vetor, celula hospedeira, metodo para produzir o anticorpo monoclonal humano, composição farmaceutica, uso de um anticorpo monoclonal humano, kit de teste para diagnostico de p. aeruginosa em uma amostra
IN2012DN01214A (es)